Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01482754
Recruitment Status : Completed
First Posted : December 1, 2011
Last Update Posted : December 10, 2013
Information provided by (Responsible Party):
Haematology-Oncology, National University Hospital, Singapore

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2013
  Study Completion Date : April 2013